spacer
home > ebr > winter 2019 > consent and biospecimen collection in human research
PUBLICATIONS
European Biopharmaceutical Review

Consent and Biospecimen Collection in Human Research

Regulations governing the protection of human research subjects are based on the ethical principles identified in the Belmont Report: “respect for persons, beneficence, and justice” and in the Nuremberg Code and the Declaration of Helsinki (1-3). Guidelines established by the Council for the International Organization of Medical Sciences, the Nuffield Council on Bioethics, and Good Clinical Practice also contributed (4-6). The application of these principles in the use of human biospecimens in research is enforced by legal and ethical regulations, the most important of which relates to permission. This may come directly from the donor or be granted by others with authorisation to protect the interests of biospecimen donors.

Legal and ethical oversight is country/region-specific. In the UK, consent or authorisation is required for the collection of biospecimens for research from both living and deceased donors, with a similar situation existing in other European countries. However, in the UK, whether or not a research study also requires ethical approval by an independent ethics committee (IEC) can be determined via an online tool provided by the Health Research Authority (7). In the US, institutional review boards (IRBs) are responsible for the regulatory oversight of research involving human subjects, with the Office of Human Research Protection (OHRP) 45 CFR Part 46 regulations governing IRBs and their operation (8). In other countries, the ministries of health (MOH) or their equivalent may be responsible or may transfer the responsibility to authorised IECs.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Tony Brown is Senior Director of Scientific and Corporate Development at BioIVT. Kelly Sapsford is General Manager for the UK and Europe at BioIVT.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Protagen Protein Services (PPS) reaches new level in characterizing HCP protein impurities

In response to current regulatory guidance a Mass Spectrometry (MS) based Host Cell Protein (HCP) detection approach with faster, more accurate and wider-ranging detection is essential. In order to meet the newly prevailing demands Protagen Protein Services (PPS) recently invested in more far-reaching MS capabilities: The new high-performing mass spectrometer ThermoFisher Q Exactive™ HF-X started operational service last month and brings PPS to the next level of reproducible, accurate and sensitive analyses of majorly complex samples for different aspects of translational research and biopharma applications.
More info >>

White Papers

8 Ways To Reduce Tablet Manufacturing Costs

Natoli Engineering Company, Inc.

It’s no surprise that in today’s economy, companies are facing budget cuts across the board. In an effort to address these challenges, this list of 8 Ways to Reduce Tablet Manufacturing Costs was compiled.
More info >>

 
Industry Events

14th Annual Biomarkers Congress

21-22 February 2019, Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 – 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement